Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,042 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a formal disclosure sent by Dabur India Ltd under Regulation 30 of SEBI’s Listing Obligations & Disclosure Requirements, providing a schedule of upcoming analyst/institutional investor meetings. It contains no financial statements, presentation slides, vote results, dividend details, or management changes; rather, it is a routine compliance announcement to stock exchanges. This fits the general category of miscellaneous regulatory filings (RNS).
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 84% confidence The document is a notice sent by Dabur India Ltd to stock exchanges under SEBI Listing Obligations & Disclosure Requirements Regulation 30. It informs about the schedule of investor/analyst meets, with date, time, venue and nature of conferences. It is a regulatory compliance announcement rather than a substantive financial report, earnings release, management discussion, or investor presentation. It is not a form of Annual/Quarterly Report, nor is it an earnings release, proxy document, or board change notice. This falls under the miscellaneous regulatory announcements category. Thus, it should be classified as Regulatory Filings (RNS).
2026-05-25 English
Submission of Information under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Schedule of Analyst/ Institutional Investor Meet
Regulatory Filings Classification · 22% confidence The document is a short compliance disclosure under SEBI Listing Regulations, informing stock exchanges of the schedule for analyst/institutional investor meetings. It contains no financial statements, no forms, nor details of a report attachment. It is a regulatory announcement/fall-back disclosure. Therefore, it falls under Regulatory Filings (RNS).
2026-05-25 English
Submission of Information under Regulation 30 of SEBI (LODR) Regulations, 2015- Schedule of Analyst/Institutional Investor Meet
Regulatory Filings Classification · 85% confidence The document is a regulatory announcement submitted under SEBI Listing Regulations (Regulation 30) to stock exchanges, providing the schedule of analyst/institutional investor meets. It contains no financial statements, no executive changes, no voting results, and is not an investor presentation itself. It is a general compliance announcement, fitting the fallback category of Regulatory Filings (RNS).
2026-05-25 English
Acquisition
Regulatory Filings Classification · 95% confidence The document is very short (801 characters) and contains no substantive text or financial data, only references to omitted pictures and a digital signature. There is no indication of financial results, management discussion, voting results, or any detailed report content. The presence of a digital signature and lack of report content suggests this is likely a certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2026-05-19 English
Incorporation of Step-Down Wholly Owned Subsidiary company of Dabur India Limited- update on letter dated May 06, 2026
Regulatory Filings Classification · 80% confidence The document is a formal SEBI Regulation 30 disclosure letter to BSE and NSE regarding the incorporation of a step-down wholly owned subsidiary by Dabur India Limited. It does not contain financial statements, earnings data, or executive compensation details, nor is it announcing dividends, AGM materials, or a takeover proposal. It is a statutory update/disclosure under listing rules, making it a regulatory announcement. Therefore, it falls under Regulatory Filings (RNS).
2026-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.